HYBRID EVENT: Join us in person in Boston, Massachusetts, USA or attend virtually from anywhere.
13th Edition of International Conference on Neurology and Brain Disorders
October 19-21, 2026
Neurobiology and Behavior
Neurobiology and Behavior
The Intellectual Basis: Neurobiology is concerned with, unveiling the biological mechanisms by which nervous systems mediate behavior. The MBB Track in Neuroscience (formerly Neurobiology) is planned to provide students with the tools to study nervous systems biologically from molecules to behavior. Neuroscientists focus on the brain and its effect on behavior and cognitive functions, or how people think. They also examine what happens to the nervous system when people have neurological, psychiatric, and neurodevelopmental disorders.
- Neurophysiology.
- Neuroanatomy.
- Neuropharmacology.
- Behavioral neuroscience.
- Developmental neuroscience.
- Cognitive neuroscience.
- Systems neuroscience.
- Molecular neuroscience.
Committee Members
Ken Ware
NeuroPhysics Therapy Institute and Research Centre, Australia
Yong Xiao Wang
Albany Medical College, United States
Joe Sam Robinson
Mercer University, United States INBC 2026 Speakers
Daniel Curry
Texas Children’s Hospital, United States
Steven Benvenisti
Davis, Saperstein Salomon, PC, United States
Andrzej Stanislaw Cieplak
Independent researcher, United States
Younok Dumortier Shin
OnusBio, United StatesSubmit your abstract Today
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States